These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 15707852

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
    Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC, Semprini MC, Gerlach RF, Cunha FQ, Tanus-Santos JE.
    Crit Care Med; 2007 Jan; 35(1):239-45. PubMed ID: 17133179
    [Abstract] [Full Text] [Related]

  • 26. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
    Chau EM, Fan KY, Chow WH.
    Int J Cardiol; 2007 Sep 03; 120(3):301-5. PubMed ID: 17174418
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
    Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hübler M, Butrous G, Petros A, Lange P, Redington AN.
    Circulation; 2003 Sep 09; 108 Suppl 1():II167-73. PubMed ID: 12970227
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.
    Circulation; 2007 Oct 02; 116(14):1555-62. PubMed ID: 17785618
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
    Noori S, Friedlich P, Wong P, Garingo A, Seri I.
    Neonatology; 2007 Oct 02; 91(2):92-100. PubMed ID: 17344658
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension.
    Karatza AA, Bush A, Magee AG.
    Int J Cardiol; 2005 Apr 20; 100(2):267-73. PubMed ID: 15823634
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
    Lim ZS, Salmon AP, Vettukattil JJ, Veldtman GR.
    Int J Cardiol; 2007 May 31; 118(2):178-82. PubMed ID: 17027100
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome.
    Shekerdemian LS, Ravn HB, Penny DJ.
    Pediatr Res; 2004 Mar 31; 55(3):413-8. PubMed ID: 14711900
    [Abstract] [Full Text] [Related]

  • 37. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadaş B, Schermuly RT, Weissmann N, Seeger W, Grimminger F.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1488-96. PubMed ID: 15464333
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Sildenafil for pulmonary hypertension.
    Lee AJ, Chiao TB, Tsang MP.
    Ann Pharmacother; 2005 May 06; 39(5):869-84. PubMed ID: 15827074
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.